These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2042678)

  • 1. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration.
    Lor E; Sheybani T; Takagi J
    Am J Hosp Pharm; 1991 Apr; 48(4):744-6. PubMed ID: 2042678
    [No Abstract]   [Full Text] [Related]  

  • 2. Visual compatibility of fluconazole with drugs given by continuous infusion.
    Ishisaka DY
    Am J Hosp Pharm; 1994 Sep; 51(18):2290, 2292. PubMed ID: 7801993
    [No Abstract]   [Full Text] [Related]  

  • 3. Stability of paclitaxel and fluconazole during simulated Y-site administration.
    Burm JP; Choi JS; Jhee SS; Chin A; Ulrich RW; Gill MA
    Am J Hosp Pharm; 1994 Nov; 51(21):2704-6. PubMed ID: 7856586
    [No Abstract]   [Full Text] [Related]  

  • 4. Stability of ranitidine hydrochloride with ondansetron hydrochloride or fluconazole during simulated Y-site administration.
    Pompilio FM; Fox JL; Inagaki K; Burm JP; Jhee S; Gill MA
    Am J Hosp Pharm; 1994 Feb; 51(3):391-4. PubMed ID: 8160697
    [No Abstract]   [Full Text] [Related]  

  • 5. Compatibility of ondansetron hydrochloride with fluconazole, ceftazidime, aztreonam, and cefazolin sodium under simulated Y-site conditions.
    Bosso JA; Prince RA; Fox JL
    Am J Hosp Pharm; 1994 Feb; 51(3):389-91. PubMed ID: 8160696
    [No Abstract]   [Full Text] [Related]  

  • 6. Stability and compatibility of fluconazole and aminophylline in intravenous admixtures.
    Johnson CE; Jacobson PA; Pillen HA; Woycik CL
    Am J Hosp Pharm; 1993 Apr; 50(4):703-6. PubMed ID: 8470689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration.
    Baltz JK; Kennedy P; Minor JR; Gallelli J
    Am J Hosp Pharm; 1990 Sep; 47(9):2075-7. PubMed ID: 2145761
    [No Abstract]   [Full Text] [Related]  

  • 8. Visual compatibility of esmolol hydrochloride and various injectable drugs during simulated Y-site injection.
    Colucci RD; Cobuzzi LE; Halpern NA
    Am J Hosp Pharm; 1988 Mar; 45(3):630-2. PubMed ID: 2897164
    [No Abstract]   [Full Text] [Related]  

  • 9. Visual compatibility of diltiazem with commonly used injectable drugs during simulated Y-site administration.
    Zanetti LA
    Am J Hosp Pharm; 1992 Aug; 49(8):1911. PubMed ID: 1442831
    [No Abstract]   [Full Text] [Related]  

  • 10. Visual compatibility of neuromuscular blocking agents with various injectable drugs during simulated Y-site injection.
    Savitsky ME
    Am J Hosp Pharm; 1990 Apr; 47(4):820-1. PubMed ID: 1969713
    [No Abstract]   [Full Text] [Related]  

  • 11. Visual compatibility of morphine sulfate and meperidine hydrochloride with other injectable drugs during simulated Y-site injection.
    Pugh CB; Pabis DJ; Rodriguez C
    Am J Hosp Pharm; 1991 Jan; 48(1):123-5. PubMed ID: 2000871
    [No Abstract]   [Full Text] [Related]  

  • 12. Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection.
    Min DI; Brown T; Hwang GC
    Am J Hosp Pharm; 1992 Dec; 49(12):2964-6. PubMed ID: 1282779
    [No Abstract]   [Full Text] [Related]  

  • 13. Visual compatibility of zidovudine with other injectable drugs during simulated Y-site administration.
    Bashaw ED; Amantea MA; Minor JR; Gallelli JF
    Am J Hosp Pharm; 1988 Dec; 45(12):2532-3. PubMed ID: 3228107
    [No Abstract]   [Full Text] [Related]  

  • 14. Visual compatibility of labetalol hydrochloride injection with various injectable drugs during simulated Y-site injection.
    Colucci RD; Cobuzzi LE; Halpern NA
    Am J Hosp Pharm; 1988 Jun; 45(6):1357-8. PubMed ID: 3414706
    [No Abstract]   [Full Text] [Related]  

  • 15. Visual compatibility of famotidine with commonly used critical-care medications during simulated Y-site injection.
    Jay GT; Fanikos J; Souney PF
    Am J Hosp Pharm; 1988 Jul; 45(7):1556-7. PubMed ID: 3414721
    [No Abstract]   [Full Text] [Related]  

  • 16. Visual compatibility of fentanyl citrate with selected drugs during simulated Y-site injection.
    Marquardt ED; Lam SS
    Am J Hosp Pharm; 1994 Mar; 51(6):811-2. PubMed ID: 8010323
    [No Abstract]   [Full Text] [Related]  

  • 17. Visual compatibility of amsacrine with selected drugs during simulated Y-site injection.
    Trissel LA; Chandler SW; Folstad JT
    Am J Hosp Pharm; 1990 Nov; 47(11):2525-8. PubMed ID: 2278268
    [No Abstract]   [Full Text] [Related]  

  • 18. Visual compatibility of acyclovir sodium with commonly used intravenous drugs simulated Y-site injection.
    Forman JK; Lachs JR; Souney PF
    Am J Hosp Pharm; 1987 Jun; 44(6):1408-9. PubMed ID: 3618621
    [No Abstract]   [Full Text] [Related]  

  • 19. Compatibility of filgrastim with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Aug; 51(15):1907-13. PubMed ID: 7524319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of fluconazole in commonly used intravenous antibiotic solutions.
    Inagaki K; Takagi J; Lor E; Lee KJ; Nii L; Gill MA
    Am J Hosp Pharm; 1993 Jun; 50(6):1206-8. PubMed ID: 8517463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.